Related references
Note: Only part of the references are listed.Salvage living donor liver transplantation versus repeat liver resection for patients with recurrent hepatocellular carcinoma and Child-Pugh class A liver cirrhosis: A propensity score-matched comparison
Young-In Yoon et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2022)
Surgery for Recurrent Hepatocellular Carcinoma Achieving Long-term Survival
Tomoaki Yoh et al.
ANNALS OF SURGERY (2021)
Liver Transplantation Following Yttrium-90 Radioembolization: 15-Year Experience in 207-Patient Cohort
Ahmed Gabr et al.
HEPATOLOGY (2021)
Pathologic Response to Pretransplant Locoregional Therapy is Predictive of Patient Outcome After Liver Transplantation for Hepatocellular Carcinoma Analysis From the US Multicenter HCC Transplant Consortium
Joseph DiNorcia et al.
ANNALS OF SURGERY (2020)
Locoregional Therapy Protocols With and Without Radioembolization for Hepatocellular Carcinoma as Bridge to Liver Transplantation
Andreas G. Zori et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2020)
Recurrence Patterns and Outcomes after Resection of Hepatocellular Carcinoma within and beyond the Barcelona Clinic Liver Cancer Criteria
Diamantis I. Tsilimigras et al.
ANNALS OF SURGICAL ONCOLOGY (2020)
Limitation of non-transplant treatment and proper timing for liver transplantation in patients with hepatocellular carcinoma considering long-term survival
Aya Nomura et al.
MEDICINE (2020)
Yttrium-90 trans-arterial radioembolization in advanced-stage HCC: The impact of portal vein thrombosis on survival
Francesco Somma et al.
PLOS ONE (2019)
Expanded living-donor liver transplantation criteria for patients with hepatocellular carcinoma based on the Japanese nationwide survey: the 5-5-500 rule - a retrospective study
Tsuyoshi Shimamura et al.
TRANSPLANT INTERNATIONAL (2019)
AASLD guidelines for the treatment of hepatocellular carcinoma
Julie K. Heimbach et al.
HEPATOLOGY (2018)
Development of models to predict early post-transplant recurrence of hepatocellular carcinoma that also integrate the quality and characteristics of the liver graft: A national registry study in China
Qi Ling et al.
SURGERY (2018)
Is it Time to Abandon the Milan Criteria? Results of a Bicoastal US Collaboration to Redefine Hepatocellular Carcinoma Liver Transplantation Selection Policies
Karim J. Halazun et al.
ANNALS OF SURGERY (2018)
Impact of Pretransplant Bridging Locoregional Therapy for Patients With Hepatocellular Carcinoma Within Milan Criteria Undergoing Liver Transplantation Analysis of 3601 Patients From the US Multicenter HCC Transplant Consortium
Vatche G. Agopian et al.
ANNALS OF SURGERY (2017)
When to consider liver transplantation in hepatocellular carcinoma patients?
Ka Wing Ma et al.
HEPATIC ONCOLOGY (2017)
Y90 Radioembolization Significantly Prolongs Time to Progression Compared With Chemoembolization in Patients With Hepatocellular Carcinoma
Riad Salem et al.
GASTROENTEROLOGY (2016)
Complete Pathologic Response to Pretransplant Locoregional Therapy for Hepatocellular Carcinoma Defines Cancer Cure After Liver Transplantation Analysis of 501 Consecutively Treated Patients
Vatche G. Agopian et al.
ANNALS OF SURGERY (2015)
Ischemia Time Impacts Recurrence of Hepatocellular Carcinoma After Liver Transplantation
Shunji Nagai et al.
HEPATOLOGY (2015)
Does pathological response after transarterial chemoembolization for hepatocellular carcinoma in cirrhotic patients with cirrhosis predict outcome after liver resection or transplantation?
Marc-Antoine Allard et al.
JOURNAL OF HEPATOLOGY (2015)
Image-Guided Ablation of Malignant Liver Tumors: Recommendations for Clinical Validation of Novel Thermal and Non-Thermal Technologies - A Western Perspective
Riccardo Lencioni et al.
LIVER CANCER (2015)
Clinicopathology of recurrent hepatocellular carcinomas after radiofrequency ablation treated with salvage surgery
Naoki Yamamoto et al.
HEPATOLOGY RESEARCH (2014)
Incomplete Radiofrequency Ablation Enhances Invasiveness and Metastasis of Residual Cancer of Hepatocellular Carcinoma Cell HCCLM3 via Activating β-Catenin Signaling
Ning Zhang et al.
PLOS ONE (2014)
Validation of Organ Procurement and Transplant Network (OPTN)/United Network for Organ Sharing (UNOS) Criteria for Imaging Diagnosis of Hepatocellular Carcinoma
Kathryn J. Fowler et al.
TRANSPLANTATION (2013)
Resection or Transplantation for Early Hepatocellular Carcinoma in a Cirrhotic Liver Does Size Define the Best Oncological Strategy?
Rene Adam et al.
ANNALS OF SURGERY (2012)
Local-Regional Treatment of Hepatocellular Carcinoma
Riccardo Lencioni et al.
RADIOLOGY (2012)
Radiofrequency ablation induces dedifferentiation of hepatocellular carcinoma
Hidehiro Tajima et al.
ONCOLOGY LETTERS (2010)
A Comparative Analysis of Transarterial Downstaging for Hepatocellular Carcinoma: Chemoembolization Versus Radioembolization
R. J. Lewandowski et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2009)
Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis
Vincenzo Mazzaferro et al.
LANCET ONCOLOGY (2009)
Ischemia-reperfusion of small liver remnant promotes liver tumor growth and metastases - Activation of cell invasion and migration pathways
Kwan Man et al.
LIVER TRANSPLANTATION (2007)
Growth rate of locally recurrent hepatocellular carcinoma after transcatheter arterial chemoembolization: Comparing the growth rate of locally recurrent tumor with that of primary hepatocellular carcinoma
Mikio Tezuka et al.
DIGESTIVE DISEASES AND SCIENCES (2007)
Pre-liver transplantation locoregional adjuvant therapy for hepatocellular carcinoma as a strategy to improve longterm survival
Ankit Bharat et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2006)
Early-stage hepatocellular carcinoma in patients with cirrhosis: Long-term results of percutaneous image-guided radiofrequency ablation
R Lencioni et al.
RADIOLOGY (2005)
Liver transplantation for hepatocellular carcinoma: Expansion of the tumor size limits does not adversely impact survival
FY Yao et al.
HEPATOLOGY (2001)